Clinical Trial Update: Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for anlotinib as neoadjuvant treatment in locally advanced thyroid cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Anlotinib (anlotinib)

Snippet

Sponsor: Fudan University | Conditions: Thyroid Cancer | Phase 2 | Status: UNKNOWN